Intrathecal baclofen: Does tolerance occur?
dc.authorscopusid | 7004407667 | |
dc.authorscopusid | 7003263395 | |
dc.authorscopusid | 7005038010 | |
dc.authorscopusid | 57189392391 | |
dc.authorscopusid | 35616020100 | |
dc.contributor.author | Akman M.N. | |
dc.contributor.author | Loubser P.G. | |
dc.contributor.author | Donovan W.H. | |
dc.contributor.author | O’Neill M.E. | |
dc.contributor.author | Rossi C.D. | |
dc.date.accessioned | 2024-08-04T19:59:12Z | |
dc.date.available | 2024-08-04T19:59:12Z | |
dc.date.issued | 1993 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Concern over the development of tolerance in patients on continuous intrathecal baclofen therapy has arisen as this new form of treatment for spasticity has gained wider use. We have studied time-dose relationships in 18 spinal cord injured patients who have undergone intrathecal baclofen infusion pump implantation since February 1988 in our facility. Our data show that there was a significant increase in baclofen dosage needed to control spasticity during the first 12 months post implantation. After 12 months, however, no significant change in dosage requirement was detected. In addition, there was no significant difference between completely and incompletely spinal cord injured patients with regard to both the initial dose and the tolerance trend. © 1993 International Medical Society of Paraplegia. | en_US |
dc.description.sponsorship | H133N00016-91; National Institute on Disability and Rehabilitation Research, NIDRR | en_US |
dc.description.sponsorship | This work was supported in part by a grant from the National Institute on Disability and Rehabilitation Research, US Department of Education, Grant Number H133N00016-91. | en_US |
dc.identifier.doi | 10.1038/sc.1993.84 | |
dc.identifier.endpage | 520 | en_US |
dc.identifier.issn | 0031-1758 | |
dc.identifier.issue | 8 | en_US |
dc.identifier.pmid | 8414636 | en_US |
dc.identifier.scopus | 2-s2.0-0027199266 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 516 | en_US |
dc.identifier.uri | https://doi.org/10.1038/sc.1993.84 | |
dc.identifier.uri | https://hdl.handle.net/11616/90452 | |
dc.identifier.volume | 31 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Paraplegia | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Intrathecal baclofen | en_US |
dc.subject | Spasticity | en_US |
dc.subject | Spinal cord injury | en_US |
dc.subject | Tolerance | en_US |
dc.title | Intrathecal baclofen: Does tolerance occur? | en_US |
dc.type | Article | en_US |